Invirsa develops global patent portfolio directed to INV-102
Client(s) Invirsa, Inc.
Jones Day represents Invirsa, Inc. in the establishment of a global patent portfolio related to INV-102, a small molecule immune response modulator.
Client(s) Invirsa, Inc.
Jones Day represents Invirsa, Inc. in the establishment of a global patent portfolio related to INV-102, a small molecule immune response modulator.